Formulation Freedom in Clinical Development: Why Fill2Weight Matters
In early-stage pharmaceutical development, poor powder flow is rarely the root issue, it’s simply a symptom. The real challenge for formulation...
Dr. Dave Seaward : 20 September 2022
Cell and Gene Blog Series: Part 7 - Future ATMP Manufacturing Paradigms
We wrap up this Cell and Gene series with a final blog - 7. Follow the link to continue learning about the future of ATMPs' manufacturing paradigm.
In early-stage pharmaceutical development, poor powder flow is rarely the root issue, it’s simply a symptom. The real challenge for formulation...
Pouches are widely used in medical device packaging to provide a sterile barrier when the device itself, or its primary container, cannot inherently...
Dose Delivery Uniformity (DDU) is one of the most persistent challenges in dry-powder inhaler development, and few have tackled it more directly...